Table 3.
Antimicrobial activities.
| Compound | Inhibition zone of bacterial growth (mm) | Percentage inhibition of fungicidal growth | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P. aerugenosa | S. aureus | C. albicans | A. niger | A. flavus | |||||||||||
| 0.1% | 0.2% | 0.3% | 0.1% | 0.2% | 0.3% | 0.1% | 0.2% | 0.3% | 0.1% | 0.2% | 0.3% | 0.1% | 0.2% | 0.3% | |
| QBD | 1.2 | 1.6 | 2.8 | 1.4 | 1.8 | 3.0 | 11.2 | 13.8 | 18.3 | 10.3 | 13.4 | 20.2 | 9.8 | 13.1 | 24.2 |
| QBO | 1.1 | 2.0 | 3.0 | 1.3 | 1.6 | 2.9 | 10.3 | 12.9 | 16.9 | 8.8 | 11.9 | 18.6 | 7.8 | 11.8 | 22.3 |
| [Zn(QBD)Cl2] | 2.2 | 2.7 | 4.3 | 2.3 | 3.1 | 5.1 | 13.2 | 20.5 | 29.6 | 13.2 | 16.9 | 23.2 | 12.4 | 15.2 | 27.5 |
| [Cd(QBD)Cl2] | 1.8 | 2.4 | 3.9 | 2.0 | 2.8 | 4.3 | 12.9 | 18.5 | 25.6 | 12.1 | 16.0 | 22.4 | 11.3 | 14.3 | 26.3 |
| [Co(QBD)2Cl2] | 1.6 | 2.0 | 3.4 | 1.7 | 2.3 | 3.6 | 12.7 | 15.9 | 23.0 | 11.3 | 14.5 | 21.5 | 10.6 | 13.6 | 25.2 |
| [Ni(QBD)2Cl2] | 1.5 | 2.0 | 3.2 | 1.7 | 2.2 | 3.5 | 11.6 | 15.2 | 22.1 | 11.0 | 14.3 | 21.3 | 10.5 | 13.5 | 25.1 |
| [Zn(QBO)Cl2] | 1.8 | 3.2 | 4.2 | 2.1 | 2.9 | 4.3 | 12.3 | 19.8 | 28.5 | 11.5 | 14.9 | 21.1 | 10.2 | 14.4 | 25.3 |
| [Cd(QBO)Cl2] | 1.6 | 2.9 | 3.7 | 2.0 | 2.6 | 3.9 | 11.8 | 17.8 | 25.2 | 10.5 | 14.1 | 20.1 | 9.1 | 13.5 | 24.6 |
| [Co(QBO)2Cl2] | 1.5 | 2.6 | 3.5 | 1.6 | 2.2 | 3.4 | 11.1 | 15.6 | 22.0 | 9.8 | 13.0 | 19.3 | 8.6 | 12.9 | 23.4 |
| [Ni(QBO)2Cl2] | 1.5 | 2.5 | 3.5 | 1.6 | 2.1 | 3.3 | 11.1 | 14.9 | 21.5 | 9.7 | 12.9 | 19.2 | 8.5 | 12.8 | 23.2 |
| Streptomycin | 4.0 | 12.0 | 13.5 | 9.4 | 14.5 | 26.7 | — | — | — | — | — | — | — | — | — |
| Fluconazole | — | — | — | — | — | — | 36.2 | 55.5 | 70.0 | 36.0 | 40.0 | 65.8 | 37.5 | 48.9 | 75.4 |
| DMF | +ve | +ve | +ve | +ve | +ve | +ve | +ve | +ve | +ve | +ve | +ve | +ve | +ve | +ve | +ve |
DMF is used as control, +ve indicates growth of microbes.